Researchers have discovered a rare new type of diabetes that affects babies early in life. The condition is caused by changes ...
Johnson & Johnson's Imaavy has become the first FcRn blocker to be approved in the EU as a treatment for both adolescent and adult patients with generalised myasthenia gravis (gMG), taking on rivals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback